Wilson Therapeutics IH1_Z AH0 B_AY2_OW0_F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L K_AH1_M_P_AH0_N_IY2    B_EY1_S_T IH0_N Stockholm    Sweden    DH_AE1_T D_IH0_V_EH1_L_AH0_P_S N_AA1_V_AH0_L TH_EH1_R_AH0_P_IY0_Z F_AO1_R R_EH1_R D_IH0_Z_IY1_Z_AH0_Z The K_AH1_M_P_AH0_N_IY2 IH1_Z L_IH1_S_T_AH0_D IH0_N DH_AH0 Mid Cap S_EH1_G_M_AH0_N_T AA1_N Nasdaq Stockholm W_IH1_DH DH_AH0 S_T_AA1_K T_IH1_K_ER0 WTX Wilson Therapeutics L_EH1_D P_R_AA1_D_AH0_K_T    Decuprate    IH1_Z DH_AH0 P_R_AH0_P_R_AY1_AH0_T_EH2_R_IY0 B_IH1_S choline S_AO1_L_T AH1_V tetrathiomolybdate Decuprate IH1_Z IH2_N_IH1_SH_AH0_L_IY0 B_IY1_IH0_NG D_IH0_V_EH1_L_AH0_P_T AE1_Z AH0 N_AA1_V_AH0_L T_R_IY1_T_M_AH0_N_T F_AO1_R Wilson EH1_S D_IH0_Z_IY1_Z    AH0 R_EH1_R JH_AH0_N_EH1_T_IH0_K D_IH0_Z_IY1_Z DH_AE1_T AH0_F_EH1_K_T_S AH0_P_R_AA1_K_S_AH0_M_AH0_T_L_IY0 IH0_N 30 000    K_AA1_Z_IH0_NG K_AA1_P_ER0 OW1_V_ER0_L_OW2_D IH0_N DH_AH0 L_IH1_V_ER0    B_R_EY1_N AH0_N_D AH1_DH_ER0 T_IH1_S_Y_UW2_Z AH0_N_D R_IH0_Z_AH1_L_T_IH0_NG IH0_N AO1_R_G_AH0_N D_AE1_M_AH0_JH AH0_N_D D_IH0_S_F_AH1_NG_K_SH_AH0_N    Decuprate HH_AE1_Z B_IH1_N G_R_AE1_N_T_AH0_D AO1_R_F_AH0_N D_R_AH1_G D_EH2_Z_AH0_G_N_EY1_SH_AH0_N F_AO1_R DH_AH0 T_R_IY1_T_M_AH0_N_T AH1_V Wilson EH1_S D_IH0_Z_IY1_Z IH0_N B_OW1_TH Europe AH0_N_D DH_AH0 United States Wilson Therapeutics P_R_IY0_Z_EH1_N_T_AH0_D D_UH1_R_IH0_NG DH_AH0 10th Kempen  &  Co Life Sciences Conference 2017 AH0_N_D SH_OW1_D DH_AH0 W_ER1_L_D DH_AH0 R_IH0_Z_AH1_L_T W_IH1_DH DH_AH0 D_R_AH1_G Decuprate The K_AH1_M_P_AH0_N_IY2 AO1_L_S_OW0 P_R_IY0_Z_EH1_N_T_AH0_D D_UH1_R_IH0_NG DH_AH0 IH2_N_T_ER0_N_AE1_SH_AH0_N_AA0_L investmentconference Bioequity Europe IH0_N Paris    France    AA1_N May 23rd 2017 AH0_N_D SH_OW1_D S_AH1_M P_R_AA1_M_AH0_S_IH0_NG R_IH0_Z_AH1_L_T    As AH1_V 2016    tetrathiomolybdate HH_AE1_D B_IH1_N T_EH1_S_T_IH0_D IH0_N OW1_V_ER0 500 P_EY1_SH_AH0_N_T_S F_AO1_R AH1_P T_UW1 S_EH1_V_AH0_N Y_IH1_R_Z    P_R_AY0_M_EH1_R_AH0_L_IY0 IH0_N AA0_NG_K_AA1_L_AH0_JH_IY0             AH0_N_D Wilson EH1_S D_IH0_Z_IY1_Z        AE1_Z W_EH1_L AE1_Z S_AH1_M AH1_DH_ER0 K_L_IH1_N_AH0_K_AH0_L P_AH0_TH_AA1_L_AH0_JH_IY0_Z     Wilson Therapeutics W_AA1_Z F_AW1_N_D_IH0_D IH0_N 2012 B_AY1 HealthCap    W_AH1_N AH1_V DH_AH0 L_IY1_D_IH0_NG European L_AY1_F S_AY1_AH0_N_S V_EH1_N_CH_ER0 K_AE1_P_IH0_T_AH0_L F_AH1_N_D_Z    In 2014    Wilson Therapeutics K_L_OW1_Z_D AH0  $ 40 M_IH1_L_Y_AH0_N Series F_AH0_N_AE1_N_S_IH0_NG K_OW1 L_EH1_D B_AY1 N_UW1 IH2_N_V_EH1_S_T_ER0_Z    Abingworth LLP    MVM Life Science Partners LLP AH0_N_D NeoMed Management AS HealthCap AO1_L_S_OW0 P_AA0_R_T_IH1_S_AH0_P_EY2_T_AH0_D IH0_N DH_AH0 R_AW1_N_D     On April 29    2016    Wilson Therapeutics AH0_N_AW1_N_S_T IH1_T_S IH2_N_IH1_SH_AH0_L P_AH1_B_L_IH0_K AO1_F_ER0_IH0_NG AA1_N Nasdaq Stockholm AH0_N_D HH_AE1_D IH1_T_S F_ER1_S_T D_EY1 AH1_V T_R_EY1_D_IH0_NG AA1_N May 12    2016    